The Therapeutic Antibody Tregalizumab (BT-061) Induces Activation of Regulatory T Cells by Engaging a Unique CD4 Mediated Signaling That Strongly Differs From Signaling Events Induced by Standard Anti-CD4 Antibodies

Bianca Helling,Benjamin Daelken,Holger Wallmeier,Silke Aigner,Chantal Zuber,Martin Koenig,Andre Engling,Frank Osterroth,Niklas Czeloth,Christoph Uherek

ARTHRITIS AND RHEUMATISM（2012）

引用 0|浏览3

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要